View Older Stories View More Recent Stories
-
BMO Capital Came Away from ZIOPHARM (ZIOP) Meeting 'Impressed'
-
BMO Capital Downgrades Westamerica Bancorp (WABC) to Underperform
-
BMO Capital Downgrades Greif Inc. (GEF) to Underperform
-
BMO Capital Starts Costco Wholesale (COST) at Outperform
-
Physicians Realty Trust (DOC) Prices Upsized 16.5M Common Offering at $16.40/Share
-
Southwestern Energy (SWN) Prices Larger 26.09M Common Offering at $23/Share; Prices 30M Depositary Shares
-
BMO Capital Upgrades Mosaic (MOS) to Outperform
-
Physicians Realty Trust (DOC) Announces 15M Common Offering
-
BMO Capital Upgrades ZIOPHARM Oncology (ZIOP) Two-Notches to Outperform; 'CAR-T Alliance Is Transformational'
-
BMO Capital Upgrades Skyworks Solutions (SWKS) to Outperform
-
BMO Capital Upgrades Agnico-Eagle Mines Ltd. (AEM) to Outperform
-
BMO Capital Starts Rice Midstream Partners (RMP) at Outperform
-
Southwestern Energy (SWN) Announces 20.26M Common, 26M Depositary Shares Offering
-
Rosetta Resources Inc. to Participate in Upcoming Conferences
-
BMO Capital Downgrades Polaris Industries (PII) to Market Perform
-
Box, Inc. (BOX) Sees IPO Price of $11 - $13/Share
-
Regulus Therapeutics (RGLS) Gains on Clinical Map Update; BMO Capital Sees Multiple Opportunities to Realize Value
-
Notable Analyst Rating Changes 1/8: (MGM) (WEN) (TSCO) Upgraded; (AIG) (ADM) (DKS) Downgraded
-
BMO Capital Downgrades Kate Spade (KATE) to Market Perform
-
BMO Capital Downgrades The Andersons, Inc. (ANDE) to Market Perform
-
BMO Capital Downgrades Archer Daniels Midland (ADM) to Market Perform
-
Halozyme Therapeutics (HALO) Surges Following Impressive Data for PEGPH20 in Pancreatic Cancer from Investor Day
-
Eli Lilly's 2015 Guidance Shows That Zoetis (ZTS) is Undervalued - BMO Capital
-
Arena Pharma (ARNA) APD334 Data Positive But Well Behind S1P1 Competitors - BMO Capital
-
BMO Capital Downgrades Mallinckrodt plc (MNK) to Market Perform
-
BMO Capital Upgrades Centene (CNC) to Outperform
-
BMO Capital Starts James River Group Holdings (JRVR) at Outperform
-
Notable Analyst Rating Changes 1/5: (LULU) (SKUL) (INTC) Upgraded; (SKH) (SBUX) (CVC) Downgraded
-
BMO Capital Starts Qorvo Inc (QRVO) at Market Perform
-
Notable Analyst Rating Changes 12/23: (ATW) (KMB) (CHD) Upgraded; (ACHN) (AVP) (RIG) Downgraded
-
BMO Capital Upgrades Kimberly Clark (KMB) to Outperform
-
BMO Capital Upgrades Church & Dwight Co. Inc. (CHD) to Outperform
-
BMO Capital Downgrades Avon Products (AVP) to Underperform
-
Streetinsider.com's Hot Lunchtime Reads 12/22: (GILD) (CUBA) (VHC) (ACHN)
-
Buy Gilead Sciences (GILD) on Weakness, BMO Capital Says; PT Dropped $20 on News
-
AbbVie's (ABBV) VIEKIRA PAK Seen as Limited Threat to Gilead's (GILD) HCV Dominance, BMO Capital Says
-
Celgene (CELG) Bullish Stance Reiterated at BMO Capital Amid Expanded EU Labeling
-
BMO Capital Starts LDR Holding (LDRH) at Outperform
-
Tetraphase Pharmaceuticals (TTPH) PT Raised to $48 at BMO Capital
-
Valeant Pharmaceuticals (VRX) Named Top Pick for 2015 at BMO Capital
-
Auspex Pharmaceuticals (ASPX) SD-809 Results 'Stunning', BMO Capital Says; PT Raised to $60
-
LendingClub (LC) IPO Tops $1B Following Over-Allotments
-
Devry (DV) Brasil Announces Agreement to Acquire Damásio Educacional
-
Genfit Data Not Seen as Competitive Threat to Intercept Pharmaceuticals (ICPT) - BMO Capital
-
Patriot National, Inc. (PN) Files for $100M IPO
-
BMO Capital Downgrades EnCana Corp. (ECA) to Market Perform
-
BMO Capital Upgrades Enerplus (ERF) to Market Perform
-
BMO Capital Downgrades Cenovus Energy Inc. (CVE) to Market Perform
-
BMO Capital Upgrades ExxonMobil (XOM) to Market Perform
-
UPDATE: Credit Suisse Positive on Canadian Banks; Downgrades CIBC (CM), Upgrades BMO (BMO)


